Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Vanguard Health Care ETF (NY:VHT)

305.38 -1.77 (-0.58%)

Streaming Delayed Price Updated: 2:28 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanguard Health Care ETF

< Previous 1 2 3 4 5 Next >

The Healthcare Stock Play That Could Make Millennials Rich ↗

October 06, 2025

This investment may also make baby boomers, and those from Gen X and Gen Z, rich as well.

Via The Motley Fool

Topics ETFs

Trump Admin Targets Medicaid Spending On Immigrants, Threatening Over $12 Billion California Program ↗

September 06, 2025

The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse in immigrant healthcare programs.

Via Benzinga

Topics Government

Trump-nominee Susan Monarez Confirmed As CDC Director By Senate ↗

July 30, 2025

According to a report by Reuters, the Senate voted 51-47 along party lines to confirm the President’s nominee.

Via Stocktwits

Topics Government Workforce

Here's Why Vanguard's Worst-Performing Sector ETF Is a No-Brainer Buy Right Now ↗

July 21, 2025

Via The Motley Fool

Topics Artificial Intelligence ETFs

US Supreme Court Reportedly Upholds Part Of Obamacare That Guarantees Health Insurers Cover Preventive Care ↗

June 27, 2025

The Obamacare law requires health insurers to provide preventive care, including cancer screenings and HIV prevention medication, at no cost to patients.

Via Stocktwits

Topics Government Lawsuit Religion

UnitedHealth Reportedly Draws Bids Worth $1B For Banmedica In Latin America Exit ↗

June 09, 2025

According to Reuters, UnitedHealth has received four preliminary bids for Banmedica and could set a deadline for binding offers as early as July.

Via Stocktwits

Topics Fraud

Regeneron Stock Drops On Mixed Results For Smoker’s Lung Treatment ↗

May 30, 2025

Both trials were conducted during the COVID-19 pandemic, a factor the companies said may have influenced the outcomes.

Via Stocktwits

Topics Government Stocks

Merus Stock Soars On Positive Phase 2 Drug Trial Data, Price Target Hikes: Retail’s Thrilled ↗

May 23, 2025

BofA’s new price target of $92 implies a 121% upside to Merus’s closing share price of $41.6 on Thursday.

Via Stocktwits

Creating A Sector-Based ETF Portfolio ↗

April 19, 2025

A sector-based ETF portfolio provides an effective way to navigate these market rhythms, allowing investors to position their assets for potential outperformance.

Via Talk Markets

Topics ETFs

RFK Jr.'s Massive Federal Health Workforce Cut Could Take 'Decades To Rebuild,' Warn Experts: 'We Cannot Accurately Assess Whether We Are Truly Making America Healthier' ↗

April 14, 2025

Experts raise alarms about Health Secretary Robert F. Kennedy Jr's decision to layoff tens of thousands of federal workers, disrupting critical health data collection and research efforts.

Via Benzinga

Topics Workforce

As Trump Tariffs Spark Panic, Investors Rush Into These 5 'Recession-Proof' ETFs ↗

April 08, 2025

ETFs that provide exposure to sectors that have historically been considered defensive during downturns are now in the limelight.

Via Benzinga

Topics ETFs Government

Best Blue-Chip ETFs To Buy As Donald Trump’s Trade War Escalates ↗

March 30, 2025

Investing in defensive ETFs may be a good way to weather the storm.

Via Talk Markets

Topics ETFs Government World Trade

Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too? ↗

March 28, 2025

Via The Motley Fool

Topics ETFs Economy Government

Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals ↗

March 28, 2025

Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue...

Via Stocktwits

Topics Bankruptcy

HealthEquity Stock Sees Biggest Drop In Over 3 Years On Disappointing Outlook — Retail Doesn't Feel It's All Doom And Gloom ↗

March 20, 2025

CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.

Via Stocktwits

Topics Earnings Fraud

Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors ↗

March 17, 2025

Via The Motley Fool

Topics Government

Healthcare Sector Trying To Bounce Back ↗

March 09, 2025

I often discuss highly rated stocks that are part of highly rated sectors. Thus, this time is a departure from the norm. Let's dive into the data for the healthcare sector.

Via Talk Markets

Topics ETFs Stocks / Equities

Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates ↗

March 05, 2025

Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years.

Via Stocktwits

Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars? ↗

March 04, 2025

Healthcare performed terribly in 2023 and 2024, falling while the market was soaring. Year-to-date, the sector has outperformed. Is it time to focus on the stocks and ETFs of this low-Beta sector as...

Via Talk Markets

Topics ETFs Stocks / Equities

These Vanguard ETFs Show Where the Smart Money Is Moving Now ↗

March 03, 2025

Via The Motley Fool

Topics ETFs

Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025 ↗

March 02, 2025

Via The Motley Fool

Topics Stocks

Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗

February 24, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

Via Stocktwits

Topics Earnings

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update ↗

February 24, 2025

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.

Via Stocktwits

Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided ↗

February 19, 2025

One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance.

Via Stocktwits

Hims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This Path ↗

February 18, 2025

A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking.

Via Stocktwits

US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget ↗

February 11, 2025

A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21.

Via Benzinga

Prediction: The 2 Best Vanguard Index Funds in January Will Beat the S&P 500 in 2025 ↗

February 02, 2025

Via The Motley Fool

Topics Stocks

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

ETFs In Focus Post UnitedHealth's Mixed Q4 Results ↗

January 18, 2025

UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the...

Via Talk Markets

Topics ETFs Stocks / Equities

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Vanguard Health Care ETF (NY:VHT)

All News about Vanguard Health Care ETF